// App-Quantinova.ai

592 : Improving therapeutic activity of agonistic DR5 antibodies by inducing target binding-dependent hexamer formation

Researchers

Presenter

  • Marije B. Overdijk

Principal Investigators

  • Kristin Strumane

  • Antonio Ortiz Buijsse

  • Claudine Vermot-Desroches

  • Andreas Lingnau

  • Esther C.W. Breij

  • Janine Schuurman

  • Paul W.H.I. Parren

Medical Centers

  • Genmab, Utrecht, Netherlands

  • iDD biotech, Lyon, France.

Locations

  • France

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Immunoglobulin G

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved